Attention Deficit Hyperactivity Disorder Clinical Trial
Official title:
A Nutritional and Social Skills Intervention on Conduct Disorder and Hyperactivity
This is a 36-week, randomised, double-blind, placebo-controlled trial. The overarching aim of this study is to assess whether a nutritional intervention (Omega-3 supplement), when combined with a more traditional treatment approach to conduct disorder and Attention Deficit Hyperactivity Disorder (ADHD), is more effective than either approach alone in treating these conditions in children and adolescents. The research questions cannot be answered through alternative means because disruptive behaviour disorders are primarily childhood disorders.
Serious adult crime and violence is a social problem despite decades of intervention and
prevention work. One of the reasons for the world-wide failure to prevent this problem stems
from (a) a failure to tackle the biological component of the crime/ violence equation in
treatment programs, and (b) the failure to tackle this adult condition in its formative
childhood origins. Investing modest resources in early biosocial prevention programs could
yield enormous long-term financial dividends in terms of the saved legal, medical, social,
and psychological costs resulting from adult crime. This initial study would be the first to
test the efficacy of conjoint Omega-3 plus social skills training, and the first to identify
possible mechanisms by which Omega-3 reduces antisocial behaviour.
A) Initial evidence for effects of Omega-3 supplementation on conduct disorder and Attention
Deficit Hyperactivity Disorder (ADHD) B) Moderators of the hypothesised relationship between
omega-3 supplementation and conduct disorder C) Social skills training as a treatment for
conduct disorder D) The combined effectiveness of omega-3 and social skills training E)
Mechanisms of action underlying any treatment effect
The total daily dosages will be 400 mg of DHA and 600 mg of EPA, typical of prior
intervention studies of children in the age-range in the proposed study (e.g. Itomura et al.
2005; Richardson & Puri, 2002).
The study involves children and adolescents diagnosed with disruptive behaviour disorder
(DBD, i.e. conduct disorder or oppositional defiant disorder) or attention deficit /
hyperactivity disorder (ADHD, i.e. combined type or ADHD predominantly inattentive type or
ADHD predominantly hyperactive-impulsive type). The overarching aim of this study is to
assess whether a nutritional intervention (Omega-3 supplement), when combined with a more
traditional treatment approach to conduct disorder and ADHD, is more effective than either
approach alone in treating these conditions in children and adolescents. The research
questions cannot be answered through alternative means because disruptive behaviour
disorders are primarily childhood disorders.
Violence is a world-wide public health problem that has largely defied successful
intervention and prevention. The overarching aim of this study is to assess whether a
nutritional intervention, when combined with social skills training, is more effective than
either approach alone in reducing childhood conduct disorder, the precursor to adult crime
and violence. The specific aims are:
Subjects will consist of 600 male and female children seeking treatment at the Child
Guidance Clinic.
Subjects given a primary diagnosis by the attending physician of either a disruptive
behaviour disorder (DBD, i.e. conduct disorder or oppositional defiant disorder) or
attention deficit / hyperactivity disorder (ADHD, i.e. combined type or ADHD predominantly
inattentive type or ADHD predominantly hyperactive-impulsive type) will be included.
This a randomised, double-blind, placebo-controlled trial with 4 x 3 x 4 x 2 (4 treatments
groups x 3 diagnostic groups x 4 time measurements of an outcome variable x 2 genders)
between-subject design to evaluate whether Omega-3 supplement, when combined with social
skills training, is more effective than either approach alone in reducing childhood conduct
disorder and attention deficit hyperactivity disorder.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06129396 -
Effects of Aerobic Exercise Intervention in Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT04779333 -
Lifestyle Enhancement for ADHD Program 2
|
N/A | |
Recruiting |
NCT05935722 -
Evaluation of a Home-based Parenting Support Program: Parenting Young Children
|
N/A | |
Completed |
NCT03148782 -
Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase
|
N/A | |
Completed |
NCT04832737 -
Strength-based Treatment Approach for Adults With ADHD
|
N/A | |
Recruiting |
NCT04631042 -
Developing Brain, Impulsivity and Compulsivity
|
||
Recruiting |
NCT05048043 -
Development of a Game-supported Intervention
|
N/A | |
Completed |
NCT03337646 -
Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism
|
Phase 4 | |
Not yet recruiting |
NCT06080373 -
Formulation-based CBT for Adult Inmates With ADHD: A Randomized Controlled Trial
|
N/A | |
Not yet recruiting |
NCT06406309 -
Settling Down for Sleep in ADHD: The Impact of Sensory and Arousal Systems on Sleep in ADHD
|
N/A | |
Not yet recruiting |
NCT06454604 -
Virtual Reality Treatment for Emerging Adults With ADHD
|
Phase 2 | |
Completed |
NCT02477280 -
Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance
|
Phase 4 | |
Completed |
NCT02911194 -
a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT02829970 -
Helping College Students With ADHD Lead Healthier Lifestyles
|
N/A | |
Completed |
NCT02473185 -
Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the QbTest
|
Phase 4 | |
Completed |
NCT02390791 -
New Technologies to Help Manage ADHD
|
N/A | |
Completed |
NCT02555150 -
A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD
|
Phase 3 | |
Completed |
NCT02780102 -
Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD
|
N/A | |
Recruiting |
NCT04175028 -
Neuromodulation of Executive Function in the ADHD Brain
|
N/A | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A |